Press "Enter" to skip to content

Indian Pharma’s incentives to do business in US on steady decline

In recent years, there has been a consistent decline in incentive for Indian pharma companies to do business in the US — the world’s largest pharma market.

Original source:

Also Read:   AstraZeneca vaccine's success in early human trials bodes well for Adar Poonawalla